Comparison of triple dose vs standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis

Giacomo P. Comi; Massimo Filippi; A. Campi; B Colombo; Célia da Costa Pereira; Giuseppe Scotti; N. Canal

doi:10.1016/0165-5728(95)98952-8

Back

Comparison of triple dose vs standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis

Article 1995 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1995

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.

Massimo Filippi, A. Campi, Vittorio Martinelli, B Colombo, Tarek Yousry, N. Canal, Giuseppe Scotti, Giacomo P. Comi

Article1996

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS

Massimo Filippi, Tarek Yousry, A. Campi, Christoph Kandziora, Bruno Colombo, Raymond Voltz, Vittorio Martinelli, Simone Spuler, S. Bressi, Giuseppe Scotti, Gıancarlo Comı

Article2000

Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose

Indra Yousry, Massimo Filippi, Ernst Walther, Claudio Gasperini, Ruggero Capra, Tarek Yousry

Article1996

Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.

Massimo Filippi, Ruggero Capra, A. Campi, Bruno Colombo, F. Prandini, N. Marcianò, Roberto Gasparotti, Giancarlo Comi

Article1998

Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis

Tarek Yousry, Gunter Fesl, Ernst Walther, Raymond Voltz, Massimo Filippi